Published in Hepatogastroenterology on May 17, 2004
Pyoderma gangrenosum--a review. Orphanet J Rare Dis (2007) 2.18
Cerebral venous thrombosis and heparin-induced thrombocytopenia in an 18-year old male with severe ulcerative colitis. World J Gastroenterol (2008) 0.87
Pseudotumor cerebri in a case of ulcerative colitis with sagittal sinus thrombosis. Iran J Pediatr (2013) 0.85
Cerebral venous thrombosis in ulcerative colitis. J Neurosci Rural Pract (2013) 0.80
Liver Function Test Abnormalities in Patients with Inflammatory Bowel Diseases: A Hospital-based Survey. Clin Med Insights Gastroenterol (2014) 0.79
Florid urticarial vasculitis heralding a flare up of ulcerative colitis. BMJ Case Rep (2014) 0.75
Complete resolution of non-necrotizing lung granuloma and pyoderma gangrenosum after restorative proctocolectomy in a woman with severe ulcerative colitis and cytomegalovirus infection. Clin Case Rep (2016) 0.75
2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis B. Gastroenterology (2008) 3.82
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial. Lancet (2005) 3.33
Sexual transmission of HCV between spouses. Am J Gastroenterol (2005) 2.08
Terry's nail: an overlooked physical finding in cirrhosis. Hepatobiliary Pancreat Dis Int (2013) 1.99
Heterotopic gastric mucosa in the cervical esophagus (inlet patch): endoscopic prevalence, histological and clinical characteristics. J Gastroenterol Hepatol (2004) 1.79
Cyst fluid carcinoembryonic antigen is an accurate diagnostic marker of pancreatic mucinous cysts. Pancreas (2011) 1.71
Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-2b. Gastroenterology (2008) 1.56
A randomized trial of peginterferon alpha-2a with or without ribavirin for HBeAg-negative chronic hepatitis B. Am J Gastroenterol (2010) 1.54
Heterotopic gastric mucosa in the cervical esophagus: could this play a role in the pathogenesis of laryngopharyngeal reflux in a subgroup of patients with posterior laryngitis? Scand J Gastroenterol (2005) 1.54
Is portal hypertensive enteropathy an important additional cause of blood loss in portal hypertensive patients? Scand J Gastroenterol (2010) 1.51
Response to hepatitis B vaccination in patients with celiac disease. Dig Dis Sci (2007) 1.50
Low-dose peginterferon alfa-2a is safe and produces a sustained virologic response in patients with chronic hepatitis C and end-stage renal disease. Clin Gastroenterol Hepatol (2010) 1.49
Treatment of hepatic hydrothorax with terlipressin in a cirrhotic patient. Scand J Gastroenterol (2006) 1.45
The role of gastric Helicobacter pylori infection in laryngopharyngeal reflux disease. Otolaryngol Head Neck Surg (2006) 1.41
Second-line levofloxacin-based triple therapy's efficiency for Helicobacter pylori eradication in patients with peptic ulcer. South Med J (2011) 1.39
Small bowel mucosal damage in familial Mediterranean fever: results of capsule endoscopy screening. Scand J Gastroenterol (2014) 1.39
Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: the case for continuous antiviral therapy. J Hepatol (2008) 1.36
Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels. Hepatology (2010) 1.34
Polymorphisms near IL28B and serologic response to peginterferon in HBeAg-positive patients with chronic hepatitis B. Gastroenterology (2011) 1.28
Efficacy of tenofovir in patients with Lamivudine failure is not different from that in nucleoside/nucleotide analogue-naive patients with chronic hepatitis B. Antimicrob Agents Chemother (2013) 1.14
Validation of a stopping rule at week 12 using HBsAg and HBV DNA for HBeAg-negative patients treated with peginterferon alfa-2a. J Hepatol (2012) 1.10
Occult HBV infection and YMDD variants in hemodialysis patients with chronic HCV infection. J Hepatol (2003) 1.01
The effects of rosiglitazone, metformin, and diet with exercise in nonalcoholic fatty liver disease. Dig Dis Sci (2007) 0.96
HFE gene mutation, chronic liver disease, and iron overload In Turkey. Dig Dis Sci (2007) 0.96
Quantitative HBsAg and HDV-RNA levels in chronic delta hepatitis. Liver Int (2009) 0.96
Risk factors for the transmission of hepatitis C virus infection in the Turkish population. Dig Dis Sci (2006) 0.95
Protective effect of a potent antioxidant, pomegranate juice, in the kidney of rats with nephrolithiasis induced by ethylene glycol. J Endourol (2008) 0.95
Association of the MEFV gene variations with inflammatory bowel disease in Turkey. J Clin Gastroenterol (2013) 0.94
The quality of life in hemodialysis patients with chronic hepatitis C virus infection. Turk J Gastroenterol (2009) 0.93
Hepatopulmonary syndrome in noncirrhotic portal hypertensive patients. Dig Dis Sci (2003) 0.91
Mucosa-associated lymphoid tissue lymphoma of the duodenum together with multiple intra-abdominal thromboses and hepatitis C virus infection: a case report. Cases J (2009) 0.91
Liver abscess as a rare complication of Crohn's disease: a case report. Turk J Gastroenterol (2004) 0.91
Pneumatic balloon dilatation in primary achalasia: the long-term follow-up results. Hepatogastroenterology (2005) 0.90
Anti-HDV immunoglobulin M testing in hepatitis delta revisited: correlations with disease activity and response to pegylated interferon-α2a treatment. Antivir Ther (2011) 0.89
Vanishing bile duct and Stevens-Johnson syndrome associated with ciprofloxacin treated with tacrolimus. World J Gastroenterol (2008) 0.88
Efficacy of tenofovir in adefovir-experienced patients compared with treatment-naive patients with chronic hepatitis B. Antivir Ther (2014) 0.88
Eating disorders and celiac disease: a case report. Int J Eat Disord (2006) 0.88
Association of gluten enteropathy and irritable bowel syndrome in adult Turkish population. Dig Dis Sci (2008) 0.88
Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-α2b: relation to response and HBV genotype. Antivir Ther (2012) 0.88
Prevalence and virological features of occult hepatitis B virus infection in female sex workers who work uncontrolled in Turkey. Liver Int (2008) 0.87
Terlipressin and albumin combination treatment in hepatorenal syndrome. Hepatogastroenterology (2003) 0.87